Arecor Therapeutics plc (AIM:AREC)
London
· Delayed Price · Currency is GBP · Price in GBX 70.00
+4.00 (6.06%)
Apr 28, 2026, 2:15 PM GMT
Arecor Therapeutics Revenue
In the year 2025, Arecor Therapeutics had annual revenue of 1.71M GBP, down -66.08%.
Revenue
1.71M
Revenue Growth
-66.08%
P/S Ratio
14.54
Revenue / Employee
38.95K
Employees
44
Market Cap
24.92M
Revenue Chart
Revenue History
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| SkinBioTherapeutics | 4.64M |
| ImmuPharma | -69.96K |
| Aptamer Group | 1.38M |
| Fusion Antibodies | 1.60M |
| IXICO | 6.53M |
| hVIVO | 49.66M |
| Ondine Biomedical | 1.18M |
Arecor Therapeutics News
- 5 days ago - Arecor Therapeutics Earnings Call Transcript: H2 2025 - Transcripts
- 6 weeks ago - Arecor Therapeutics Transcript: Oppenheimer 36th Annual Healthcare MedTech & Services Conference - Transcripts
- 7 months ago - Half Year 2025 Arecor Therapeutics PLC Earnings Presentation Transcript - GuruFocus
- 7 months ago - AIM Market Roundup: Wishbone, Nativo Resources, Arecor Therapeutics - The Armchair Trader
- 7 months ago - Arecor Therapeutics Earnings Call Transcript: H1 2025 - Transcripts
- 7 months ago - LGND: Ligand Pharmaceuticals Inks $11M Royalty Deal with Arecor - GuruFocus
- 7 months ago - Arecor extends cash runway with US partnerships - The Armchair Trader
- 1 year ago - AIM Market Roundup: The Revel Collective, Tanfield, Arecor - The Armchair Trader